Abstract |
|
Authors | Fadila Guessous, Ying Zhang, Charles diPierro, Lukasz Marcinkiewicz, Jann Sarkaria, David Schiff, Sean Buchanan, Roger Abounader |
Journal | Anti-cancer agents in medicinal chemistry
(Anticancer Agents Med Chem)
Vol. 10
Issue 1
Pg. 28-35
(Jan 2010)
ISSN: 1875-5992 [Electronic] Netherlands |
PMID | 20015006
(Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
|
Chemical References |
- 6-(6-(1-methyl-1H-pyrazol-4-yl)-(1,2,4)triazolo(4,3-b)pyridazin-3-ylsulfanyl)quinoline
- Antineoplastic Agents
- Protein Kinase Inhibitors
- Pyridazines
- Triazoles
- Proto-Oncogene Proteins c-met
|
Topics |
- Administration, Oral
- Animals
- Antineoplastic Agents
(pharmacokinetics, therapeutic use)
- Biological Availability
- Brain Neoplasms
(drug therapy, pathology)
- Flow Cytometry
- Glioblastoma
(drug therapy, pathology)
- Humans
- Mice
- Protein Kinase Inhibitors
(pharmacokinetics, pharmacology, therapeutic use)
- Proto-Oncogene Proteins c-met
(antagonists & inhibitors)
- Pyridazines
(pharmacokinetics, pharmacology, therapeutic use)
- Triazoles
(pharmacokinetics, pharmacology, therapeutic use)
|